Description
Background:
Reslizumab is a humanized monoclonal antibody against human interleukin-5 (IL-5).Reslizumab binds
specifically to IL-5, a key cytokine responsible for the differentiation, maturation, recruitment and activation of
human eosinophils. By binding to human IL-5, it blocks its biological function; consequently survival and activity
of eosinophils are reduced.
Intended Use:
For Estimation of Reslizumab (CINQAIR/CINQAERO) in human serum and plasma. Please note the kit has not been optimized to be used for any other animal species. Should you require a specific sera tested, please connect with us at sales@krishgen.com for optimization.
If you have published a paper by using any of our ELISA since 01/01/2023, kindly fill out the “Krishgen Publication Reward Application Form” with complete information and send it by at email: info@krishgen.com, with the subject “Krishgen Publication Reward”. We will get back to you with the Amazon / Krishgen Credit Reward after we confirm it ASAP!